10x Genomics, Inc. — insider transactions

13 transactions on record · CIK 1770787

Aggregates

computed from the filings below
Purchases, 12m
0
count of open-market buys
Sales, 12m
13
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
6
Bought, 3m
$0
Sold, 3m
$5.5M
Median disclosure lag
2.0 d
trade date to filing date
Largest single trade, 24m
$1.2M
2026-08-24
Director share, 12m
92.3%
of transactions where role is stated
Current run
13 sells
consecutive same-direction transactions
Net 3m flow
-$5.5M
purchases minus sales
Total on record
13

Transactions

13 most recent shown
DisclosedTradedLag, dInsiderRoleTransactionSharesPriceValueSource
2026-08-282026-08-262Saxonov SergeDirector, Chief Executive OfficerOpen market sale3,500$63.02$220.6Kfiling
2026-08-282026-08-262Saxonov SergeDirector, Chief Executive OfficerOpen market sale6,494$63.98$415.5Kfiling
2026-08-282026-08-262Saxonov SergeDirector, Chief Executive OfficerOpen market sale492$64.75$31.9Kfiling
2026-08-262026-08-242SULIMAN SHEHNAAZDirectorOpen market sale561$62.73$35.2Kfiling
2026-08-262026-08-242SULIMAN SHEHNAAZDirectorOpen market sale1,646$63.97$105.3Kfiling
2026-08-262026-08-242Hindson Benjamin J.Director, See RemarksOpen market sale13,818$63.02$870.9Kfiling
2026-08-262026-08-242Taich AdamChief Financial OfficerOpen market sale17,166$63.02$1.1Mfiling
2026-08-262026-08-242Saxonov SergeDirector, Chief Executive OfficerOpen market sale18,545$63.02$1.2Mfiling
2026-08-242026-08-204Saxonov SergeDirector, Chief Executive OfficerGift4,000$0.00filing
2026-08-172026-08-134Teichmann Sarah A.DirectorOpen market sale5,278$57.29$302.4Kfiling
2026-08-172026-08-143Teichmann Sarah A.DirectorOpen market sale2,273$57.15$129.9Kfiling
2026-08-132026-08-112STUELPNAGEL JOHN RDirectorOpen market sale3,000$58.73$176.2Kfiling
2026-08-132026-08-112STUELPNAGEL JOHN RDirectorOpen market sale17,000$57.58$978.9Kfiling

Source: U.S. Securities and Exchange Commission, EDGAR